The LDA termination will reduce selling pressure. Also the small discount would be very disappointing for the shorters/downrampers.
BRN is throwing the kitchen sink at commercialisation and development.
The BOD have until the next AGM to get moving, and they are aware of this.
The small discount reflects some market confidence moving forward. Obviously the Pitt Street report was produced for the benefit of Institutional investors with its $1.59 valuation and its optomistic outlook.
2024 BrainChip Discussion, page-7319
-
- There are more pages in this discussion • 3,712 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $502.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8000 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 1614 | 1 |
View Market Depth
| Last trade - 09.45am 08/11/2024 (20 minute delay) ? |
| BRN (ASX) Chart |
Day chart unavailable